Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2012-03-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2011年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "专项报告" (special report) on the "募集资金存放与使用情况" (fundraising capital deposit and usage situation) for the year 2011 by 嘉事堂药业股份有限公司. It details the amount of funds raised, their usage, management, storage, and changes in investment projects related to the raised capital. The document references regulatory approvals, audit reports, and compliance with stock exchange rules. It is a detailed report specifically about the use and management of capital raised through stock issuance, not a general annual report or earnings release. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length (9205 characters) and content indicate it is the report itself, not just an announcement of a report. Therefore, the correct classification is CAP with high confidence.
2012-03-30 Chinese
关于对公司控股股东及其他关联方占用资金情况的专项审计说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit report concerning the non-operating fund occupation and related party fund transactions of Jia Shi Tang Pharmaceutical Co., Ltd. for the year 2011. It includes an auditor's opinion, references to regulatory requirements from the China Securities Regulatory Commission, and detailed financial tables related to fund occupation and related party transactions. The document is titled as a "专项审计说明" (special audit explanation) and is issued by a registered accounting firm. It does not represent a full annual report (10-K) or interim report but is a standalone audit report focused on a specific regulatory compliance area. The document length is 2724 characters, which is sufficient for a detailed audit report but not a brief announcement. Therefore, the most appropriate classification is Audit Report / Information (AR). FY 2011
2012-03-30 Chinese
第三届董事会第十四次会议决议的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 14th meeting of the third board of directors of 嘉事堂药业股份有限公司. It includes approvals of the 2011 board work report, internal control self-evaluation report, financial statements for 2011, profit distribution plan, appointment of senior management, social responsibility report, and other corporate governance matters. The document references the 2011 annual report and other reports but does not contain the full annual report itself. It is a formal announcement of board meeting decisions, including management appointments and financial report approvals, typical of a Board/Management Information filing. The document length is 3833 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2012-03-30 Chinese
独立董事2011年度述职报告（刘建华）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of a company, covering the director's duties, attendance at meetings, independent opinions on various company matters including external guarantees, internal control evaluations, appointment of auditors, and protection of shareholder rights for the year 2011. It references compliance with regulatory guidelines and company bylaws, and discusses the preparation and communication related to the 2011 annual report. The document is substantive and contains detailed narrative and opinions rather than just an announcement or certification. It is not a full annual report (10-K) but rather a specific report by an independent director on their duties and opinions for the year, which fits the category of Board/Management Information (MANG). The length is 4065 characters, which is sufficient for a detailed report but not a full annual report. Therefore, the best classification is MANG with high confidence.
2012-03-30 Chinese
董事会关于证券投资情况的专项说明
Regulatory Filings Classification · 95% confidence The document is a special statement from the board regarding the company's securities investment situation for the year 2011. It details the company's holdings in another listed company, confirms no new securities investments were made during the period, and includes internal control and audit committee oversight statements. The document is relatively short (1099 characters) and serves as a disclosure announcement about securities investment activities rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2012-03-30 Chinese
独立董事2011年度述职报告（马永义）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2011 Annual Report" and details the independent director's duties, attendance at meetings, audit committee activities, independent opinions on various company matters, and oversight of the 2011 annual report preparation. It is a detailed report on the independent director's activities and opinions for the year 2011, which aligns with a Management Report or a detailed governance-related report. It is not a full Annual Report (10-K) or Audit Report (AR) but rather a report on the independent director's role and opinions. This fits best under Board/Management Information (MANG) as it relates to board member activities and governance oversight. The document length is 4316 characters, which is substantial but not a full financial report. Therefore, the classification is MANG with high confidence.
2012-03-30 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.